Table 3.
Enzymatic infarct size, left ventricular ejection fraction and clinical outcome.
| RCA | CX | P value | |
|---|---|---|---|
| (n=600) | (n=229) | ||
| LDHQ48 (n=588) | 1338±1117 | 1806±1498 | <0.001 |
| Peak CK (IU/l) | 1821±1735 | 2369±1948 | <0.001 |
| Peak CK-MB (IU/I) | 193±162 | 250±189 | <0.001 |
| LVEF (n=677) | 49±9 | 48±9 | 0.07 |
| EF <45% | 26% | 37% | <0.01 |
| 30-day mortality (%) | |||
| - All cause | 2.0 | 4.8 | 0.03 |
| - Cardiac | 1.5 | 4.4 | 0.01 |
| One-year mortality | |||
| - All cause | 3.7 | 7.0 | 0.04 |
| - Cardiac | 2.0 | 4.8 | 0.03 |
RCA=right coronary artery, CX=circumflex, LDHQ48=enzymatic infarct size assessed as area under the LDH release curve during the first 48 hours after admission, LVEF=left ventricular ejection fraction.